Wall Street analysts demonstrated a selective approach to equity valuations, favouring companies with identifiable earnings-growth catalysts while reducing expectations for businesses facing operational or economic uncertainty. Semiconductor infrastructure, AI-related software and select biotechnology companies attracted positive revisions, with Broadcom, Cadence Design Systems, Palantir and Xencor among notable beneficiaries. Healthcare and energy forecasts were mixed, while telecommunications and several consumer-sensitive companies experienced downward target adjustments. Overall, the day’s activity suggests analysts continue to favour stock-specific opportunities, with greater emphasis on earnings quality, valuation discipline and sustainable profitability.<\/p>\n
Abbott Laboratories (ABT) \u2014 Argus downgraded its rating from Buy to Hold.<\/p>\n
Agilysys (AGYS) \u2014 Needham maintained its Buy rating and raised its price target to $145.00 from $135.00.<\/p>\n
Agilysys (AGYS) \u2014 Oppenheimer maintained its Outperform rating and raised its price target to $135.00 from $118.00.<\/p>\n
Agilysys (AGYS) \u2014 Piper Sandler maintained its Overweight rating and raised its price target to $140.00 from $120.00.<\/p>\n
Agilysys (AGYS) \u2014 UBS established a price target of $145.00 without specifying a rating.<\/p>\n
Agree Realty (ADC) \u2014 KeyCorp maintained its Overweight rating and lowered its price target to $76.00 from $82.00.<\/p>\n
Airbnb (ABNB) \u2014 Oppenheimer maintained its Outperform rating and raised its price target to $210.00 from $190.00.<\/p>\n
Almonty Industries (ALM) \u2014 B. Riley maintained its Buy rating and lowered its price target to $20.00 from $25.00.<\/p>\n
Alphabet (GOOG) \u2014 Needham reiterated its Buy rating.<\/p>\n
American Express (AXP) \u2014 Citigroup maintained its Neutral rating and lowered its price target to $335.00 from $340.00.<\/p>\n
American Express (AXP) \u2014 Evercore established a price target of $330.00 without specifying a rating.<\/p>\n
Ameris Bancorp (ABCB) \u2014 DA Davidson maintained its Buy rating and lowered its price target to $96.00 from $100.00.<\/p>\n
Amkor Technology (AMKR) \u2014 B. Riley maintained its Neutral rating and lowered its price target to $41.00 from $46.00.<\/p>\n
Amkor Technology (AMKR) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $63.00 from $70.00.<\/p>\n
Amkor Technology (AMKR) \u2014 Needham maintained its Buy rating and lowered its price target to $55.00 from $90.00.<\/p>\n
Amkor Technology (AMKR) \u2014 Goldman Sachs established a price target of $56.00 without specifying a rating.<\/p>\n
Apollo Global Management (APO) \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $124.00 from $134.00.<\/p>\n
Apple (AAPL) \u2014 Evercore reiterated its Outperform rating.<\/p>\n
Apple (AAPL) \u2014 HSBC reiterated its Buy rating.<\/p>\n
Applied Optoelectronics (AAOI) \u2014 Needham maintained its Buy rating and lowered its price target to $170.00 from $190.00.<\/p>\n
Ardmore Shipping (ASC) \u2014 Evercore reiterated its Outperform rating with a price target of $22.00.<\/p>\n
Ares Management (ARES) \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $130.00 from $134.00.<\/p>\n
argenx (ARGX) \u2014 Citigroup maintained its Buy rating and lowered its price target to $1,232.00 from $1,301.00.<\/p>\n
ArriVent BioPharma (AVBP) \u2014 Guggenheim maintained its Buy rating and raised its price target to $30.00 from $18.00.<\/p>\n
Artiva Biotherapeutics (ARTV) \u2014 Needham downgraded its rating from Buy to Hold.<\/p>\n
Artiva Biotherapeutics (ARTV) \u2014 TD Cowen downgraded its rating from Buy to Hold.<\/p>\n
Artiva Biotherapeutics (ARTV) \u2014 Wedbush downgraded its rating from Outperform to Neutral with a price target of $4.00.<\/p>\n
Asbury Automotive Group (ABG) \u2014 Craig-Hallum upgraded its rating from Hold to Buy with a price target of $250.00.<\/p>\n
Axon Enterprise (AXON) \u2014 Needham reiterated its Buy rating.<\/p>\n
Badger Meter (BMI) \u2014 Argus upgraded its rating from Hold to Buy with a price target of $170.00.<\/p>\n
Badger Meter (BMI) \u2014 Northcoast Research downgraded its rating from Buy to Neutral.<\/p>\n
Banco Bradesco (BBD) \u2014 Citigroup’s reiteration entry recorded a change from Buy to Neutral.<\/p>\n
Banco Bradesco (BBDO) \u2014 Citigroup downgraded its rating to Neutral.<\/p>\n
Bank of Hawaii (BOH) \u2014 DA Davidson maintained its Neutral rating with a price target of $75.00.<\/p>\n
Bank of Hawaii (BOH) \u2014 Keefe, Bruyette & Woods downgraded its rating from Outperform to Market Perform and lowered its price target to $78.00 from $85.00.<\/p>\n
Bank of Marin Bancorp (BMRC) \u2014 DA Davidson maintained its Buy rating with a price target of $34.00.<\/p>\n
Baytex Energy (BTE) \u2014 Jefferies initiated coverage with a Buy rating.<\/p>\n
Beacon Financial (BBT) \u2014 Piper Sandler maintained its Overweight rating and raised its price target to $35.00 from $33.00.<\/p>\n
Beam Therapeutics (BEAM) \u2014 H.C. Wainwright reiterated its Buy rating.<\/p>\n
BellRing Brands (BRBR) \u2014 JPMorgan maintained its Overweight rating and lowered its price target to $15.00 from $18.00.<\/p>\n
Bentley Systems (BSY) \u2014 Rosenblatt reiterated its Buy rating with a price target of $50.00.<\/p>\n
Best Buy (BBY) \u2014 Evercore established a price target of $100.00 without specifying a rating.<\/p>\n
Blue Owl Capital (OWL) \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $11.00 from $12.00.<\/p>\n
Boeing (BA) \u2014 Jefferies reiterated its Buy rating.<\/p>\n
Boston Beer Company (SAM) \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to $200.00 from $190.00.<\/p>\n
BR Biopharma (BRBI) \u2014 Citigroup’s reiteration entry recorded a change from Buy to Neutral.<\/p>\n
Brixmor Property Group (BRX) \u2014 Stifel maintained its Hold rating and lowered its price target to $30.50 from $32.00.<\/p>\n
Broadcom (AVGO) \u2014 Citigroup downgraded its rating from Buy to Neutral.<\/p>\n
Broadcom (AVGO) \u2014 DA Davidson upgraded its rating from Neutral to Buy and raised its price target to $400.00 from $350.00.<\/p>\n
Broadcom (AVGO) \u2014 H.C. Wainwright initiated coverage with a Buy rating.<\/p>\n
Broadcom (AVGO) \u2014 Oppenheimer’s initiation entry listed a change from Outperform to Buy.<\/p>\n
Broadcom (AVGO) \u2014 Rosenblatt reiterated its Buy rating with a price target of $600.00.<\/p>\n
Broadcom (AVGO) \u2014 UBS downgraded its rating from Hold to Neutral.<\/p>\n
Broadcom (AVGO) \u2014 Wedbush initiated coverage with an Outperform rating.<\/p>\n
Broadcom (AVGO) \u2014 William Blair downgraded its rating from Outperform to Market Perform.<\/p>\n
Burlington Stores (BURL) \u2014 Bank of America maintained its Buy rating and lowered its price target to $344.00 from $365.00.<\/p>\n
Business First Bancshares (BFST) \u2014 DA Davidson maintained its Buy rating and raised its price target to $39.00 from $35.00.<\/p>\n
C&F Financial (CFFI) \u2014 DA Davidson reiterated its Buy rating with a price target of $115.00.<\/p>\n
CACI International (CACI) \u2014 JPMorgan maintained its Overweight rating and raised its price target to $725.00 from $715.00.<\/p>\n
Cadence Design Systems (CDNS) \u2014 JPMorgan maintained its Overweight rating and raised its price target to $420.00 from $405.00.<\/p>\n
Cadence Design Systems (CDNS) \u2014 KeyCorp reiterated its Overweight rating.<\/p>\n
Cadence Design Systems (CDNS) \u2014 Mizuho established a price target of $400.00 without specifying a rating.<\/p>\n
Cadence Design Systems (CDNS) \u2014 Needham maintained its Buy rating and raised its price target to $430.00 from $400.00.<\/p>\n
Cadence Design Systems (CDNS) \u2014 Baird maintained its Outperform rating and raised its price target to $440.00 from $420.00.<\/p>\n
CAE (CAE) \u2014 Scotiabank reiterated its Outperform rating.<\/p>\n
Cal-Maine Foods (CALM) \u2014 BMO Capital Markets reiterated its Market Perform rating.<\/p>\n
Capital One Financial (COF) \u2014 Evercore reiterated its Outperform rating with a price target of $230.00.<\/p>\n
CareDx (CDNA) \u2014 BTIG maintained its Buy rating and raised its price target to $81.00 from $74.00.<\/p>\n
Caris Life Sciences (CAI) \u2014 BTIG maintained its Buy rating and raised its price target to $38.00 from $33.00.<\/p>\n
Carlyle Group (CG) \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $46.00 from $56.00.<\/p>\n
CB Financial Services (CBFV) \u2014 DA Davidson reiterated its Buy rating with a price target of $44.00.<\/p>\n
Celestica (CLS) \u2014 TD Cowen reiterated its Buy rating.<\/p>\n
Cemex (CX) \u2014 RBC maintained its Sector Perform rating and raised its price target to $13.75 from $13.25.<\/p>\n
Cemex (CX) \u2014 Scotiabank maintained its Sector Outperform rating and lowered its price target to $13.80 from $14.50.<\/p>\n
Centrus Energy (LEU) \u2014 Capital One established a price target of $151.00 without specifying a rating.<\/p>\n
Centuri Holdings (CTRI) \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $28.00 from $29.00.<\/p>\n
CF Industries (CF) \u2014 UBS reiterated its Neutral rating.<\/p>\n
Chemung Financial (CHMG) \u2014 Raymond James reiterated its Outperform rating with a price target of $90.00.<\/p>\n
Chemung Financial (CHMG) \u2014 UBS reiterated its Outperform rating.<\/p>\n
Chubb (CB) \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to $360.00 from $350.00.<\/p>\n
Churchill Downs (CHDN) \u2014 Stifel maintained its Buy rating and lowered its price target to $132.00 from $139.00.<\/p>\n
Citizens Financial Group (CFG) \u2014 Evercore established a price target of $74.00 without specifying a rating.<\/p>\n
City Holding (CHCO) \u2014 Keefe, Bruyette & Woods maintained its Market Perform rating and raised its price target to $147.00 from $145.00.<\/p>\n
Clearwater Paper (CLW) \u2014 RBC maintained its Outperform rating and lowered its price target to $22.00 from $23.00.<\/p>\n
Clearwater Paper (CLW) \u2014 Truist maintained its Hold rating and lowered its price target to $17.00 from $20.00.<\/p>\n
Climb Bio (CLYM) \u2014 BTIG reiterated its Buy rating with a price target of $32.00.<\/p>\n
Climb Bio (CLYM) \u2014 Piper Sandler reiterated its Overweight rating.<\/p>\n
CNB Financial (CCNE) \u2014 Raymond James reiterated its Outperform rating with a price target of $40.00.<\/p>\n
Cognizant Technology Solutions (CTSH) \u2014 Guggenheim maintained its Buy rating and raised its price target to $80.00 from $65.00.<\/p>\n
Cognizant Technology Solutions (CTSH) \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to $70.00 from $51.00.<\/p>\n
Columbia Banking System (COLB) \u2014 TD Cowen maintained its Hold rating and raised its price target to $33.00 from $32.00.<\/p>\n
Community West Bancshares (CWBC) \u2014 DA Davidson maintained its Buy rating and raised its price target to $31.00 from $29.00.<\/p>\n
ConocoPhillips (COP) \u2014 Piper Sandler resumed coverage with a Neutral rating and a price target of $157.00.<\/p>\n
Constellation Brands (STZ) \u2014 RBC reiterated its Outperform rating.<\/p>\n
Criteo (CRTO) \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $15.00 from $16.00.<\/p>\n
CSX Corporation (CSX) \u2014 Susquehanna maintained its Positive rating and raised its price target to $60.00 from $55.00.<\/p>\n
Custom Truck One Source (CTOS) \u2014 Cantor Fitzgerald reiterated its Overweight rating with a price target of $14.00.<\/p>\n
Custom Truck One Source (CTOS) \u2014 DA Davidson reiterated its Buy rating with a price target of $13.00.<\/p>\n
DarioHealth (DRIO) \u2014 BTIG initiated coverage with a Buy rating and a price target of $6.00.<\/p>\n
Datadog (DDOG) \u2014 UBS reiterated its Buy rating with a price target of $320.00.<\/p>\n
Delek US Holdings (DK) \u2014 Piper Sandler resumed coverage with a Neutral rating and a price target of $90.00.<\/p>\n
DHT Holdings (DHT) \u2014 Evercore established a price target of $26.00 without specifying a rating.<\/p>\n
Dianthus Therapeutics (DNTH) \u2014 Roth Capital initiated coverage with a Buy rating and a price target of $113.00.<\/p>\n
Dick’s Sporting Goods (DKS) \u2014 BNP Paribas Exane reiterated its Underperform rating.<\/p>\n
DigitalOcean (DOCN) \u2014 Citigroup reiterated its Buy rating.<\/p>\n
DoorDash (DASH) \u2014 TD Cowen reiterated its Buy rating.<\/p>\n
Dycom Industries (DY) \u2014 Oppenheimer initiated coverage with a Market Perform rating.<\/p>\n
Dynatrace (DT) \u2014 Citigroup maintained its Buy rating and raised its price target to $75.00 from $65.00.<\/p>\n
eBay (EBAY) \u2014 UBS reiterated its Neutral rating with a price target of $131.00.<\/p>\n
Edwards Lifesciences (EW) \u2014 Deutsche Bank established a price target of $104.00 without specifying a rating.<\/p>\n
Edwards Lifesciences (EW) \u2014 TD Cowen reiterated its Buy rating.<\/p>\n
Elevance Health (ELV) \u2014 Wells Fargo maintained its Overweight rating and raised its price target to $492.00 from $473.00.<\/p>\n
Energous (WATT) \u2014 H.C. Wainwright initiated coverage with a Buy rating and a price target of $15.00.<\/p>\n
Envoy Medical (COCH) \u2014 Lake Street Capital maintained its Buy rating and raised its price target to $25.00 from $2.50.<\/p>\n
EQT Corporation (EQT) \u2014 Scotiabank maintained its Sector Perform rating and lowered its price target to $53.00 from $54.00.<\/p>\n
EQT Corporation (EQT) \u2014 Stephens maintained its Overweight rating and raised its price target to $75.00 from $71.00.<\/p>\n
EQT Corporation (EQT) \u2014 UBS established a price target of $75.00 without specifying a rating.<\/p>\n
EQT Corporation (EQT) \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $71.00 from $79.00.<\/p>\n
Ermenegildo Zegna (ZGN) \u2014 RBC initiated coverage with an Outperform rating and a price target of $16.00.<\/p>\n
eToro Group (ETOR) \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $48.00 from $53.00.<\/p>\n
Evergy (EVRG) \u2014 Truist initiated coverage with a Buy rating and a price target of $97.00.<\/p>\n
Fabrinet (FN) \u2014 Needham maintained its Buy rating and lowered its price target to $500.00 from $650.00.<\/p>\n
Fair Isaac (FICO) \u2014 Citigroup reiterated its Neutral rating.<\/p>\n
Fate Therapeutics (FATE) \u2014 Wedbush reiterated its Outperform rating with a price target of $7.00.<\/p>\n
FedEx (FDX) \u2014 Bank of America maintained its Buy rating and lowered its price target to $359.00 from $378.00.<\/p>\n
Ferguson Enterprises (FERG) \u2014 Citigroup upgraded its rating from Neutral to Buy and raised its price target to $288.00 from $285.00.<\/p>\n
Fifth Third Bancorp (FITB) \u2014 Wolfe Research resumed coverage with an Outperform rating.<\/p>\n
First BanCorp (FBP) \u2014 Raymond James reiterated its Strong Buy rating.<\/p>\n
First Solar (FSLR) \u2014 Guggenheim maintained its Buy rating and raised its price target to $299.00 from $282.00.<\/p>\n
Fiserv (FISV) \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $48.00 from $50.00.<\/p>\n
Flagstar Bank (FLG) \u2014 Cantor Fitzgerald reiterated its Overweight rating with a price target of $16.00.<\/p>\n
Flagstar Bank (FLG) \u2014 Citigroup maintained its Buy rating and lowered its price target to $14.00 from $18.00.<\/p>\n
Flex (FLEX) \u2014 Bank of America maintained its Buy rating and lowered its price target to $150.00 from $180.00.<\/p>\n
Flutter Entertainment (FLUT) \u2014 UBS reiterated its Buy rating with a price target of $130.00.<\/p>\n
Frontline (FRO) \u2014 Evercore established a price target of $53.00 without specifying a rating.<\/p>\n
Fulton Financial (FULT) \u2014 Stephens maintained its Overweight rating and lowered its price target to $25.00 from $26.00.<\/p>\n
Galaxy Digital (GLXY) \u2014 BTIG maintained its Buy rating and lowered its price target to $35.00 from $45.00.<\/p>\n
Galaxy Digital (GLXY) \u2014 Chardan Capital reiterated its Buy rating with a price target of $35.00.<\/p>\n
Genmab (GMAB) \u2014 JPMorgan upgraded its rating from Neutral to Overweight.<\/p>\n
Greenbrier Companies (GBX) \u2014 Bank of America maintained its Underperform rating and lowered its price target to $38.00 from $42.00.<\/p>\n
Guardant Health (GH) \u2014 BTIG maintained its Buy rating and raised its price target to $210.00 from $195.00.<\/p>\n
Hamilton Lane (HLNE) \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $95.00 from $116.00.<\/p>\n
Hawkins (HWKN) \u2014 BWS Financial reiterated its Buy rating with a price target of $200.00.<\/p>\n
HBT Financial (HBT) \u2014 DA Davidson established a price target of $39.00 without specifying a rating.<\/p>\n
HBT Financial (HBT) \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to $43.00 from $41.00.<\/p>\n
HBT Financial (HBT) \u2014 Piper Sandler maintained its Neutral rating and raised its price target to $40.00 from $39.00.<\/p>\n
HealthStream (HSTM) \u2014 Citigroup reiterated its Market Perform rating.<\/p>\n
Heartland Express (HTLD) \u2014 Barclays maintained its Underweight rating and lowered its price target to $10.00 from $12.00.<\/p>\n
Hershey (HSY) \u2014 RBC reiterated its Sector Perform rating.<\/p>\n
HF Sinclair (DINO) \u2014 Piper Sandler resumed coverage with an Overweight rating and a price target of $152.00.<\/p>\n
Howmet Aerospace (HWM) \u2014 Citigroup reiterated its Buy rating.<\/p>\n
HubSpot (HUBS) \u2014 Citigroup maintained its Neutral rating and raised its price target to $287.00 from $210.00.<\/p>\n
HubSpot (HUBS) \u2014 UBS downgraded its rating from Buy to Neutral and raised its price target to $310.00 from $290.00.<\/p>\n
Huntington Bancshares (HBAN) \u2014 Wolfe Research resumed coverage with a Peer Perform rating.<\/p>\n
Hyperfine (HYPR) \u2014 Loop Capital established a price target of $2.00 without specifying a rating.<\/p>\n
IDEXX Laboratories (IDXX) \u2014 UBS established a price target of $627.00 without specifying a rating.<\/p>\n
Immunome (IMNM) \u2014 H.C. Wainwright reiterated its Buy rating.<\/p>\n
Immunome (IMNM) \u2014 Wedbush reiterated its Outperform rating with a price target of $35.00.<\/p>\n
Incyte (INCY) \u2014 BMO Capital Markets reiterated its Market Perform rating.<\/p>\n
Incyte (INCY) \u2014 H.C. Wainwright reiterated its Buy rating.<\/p>\n
Incyte (INCY) \u2014 Oppenheimer established a price target of $152.00 without specifying a rating.<\/p>\n
INNIO (INIO) \u2014 BNP Paribas Exane maintained its Outperform rating and lowered its price target to $35.00 from $43.00.<\/p>\n
Innovex International (INVX) \u2014 JPMorgan initiated coverage with a Neutral rating and a price target of $33.00.<\/p>\n
Insmed (INSM) \u2014 H.C. Wainwright reiterated its Buy rating.<\/p>\n
Integra LifeSciences (IART) \u2014 UBS established a price target of $14.00 without specifying a rating.<\/p>\n
Intel (INTC) \u2014 Needham reiterated its Hold rating.<\/p>\n
Intel (INTC) \u2014 Rosenblatt reiterated its Sell rating with a price target of $80.00.<\/p>\n
Intel (INTC) \u2014 Wedbush reiterated its Neutral rating with a price target of $98.00.<\/p>\n
Investar Holding (ISTR) \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to $31.00 from $32.50.<\/p>\n
Jade Biosciences (JBIO) \u2014 BTIG reiterated its Buy rating with a price target of $77.00.<\/p>\n
JFrog (FROG) \u2014 KeyCorp reiterated its Overweight rating.<\/p>\n
Kaiser Aluminum (KALU) \u2014 UBS reiterated its Buy rating with a price target of $158.00.<\/p>\n
Kforce (KFRC) \u2014 Baird maintained its Outperform rating and raised its price target to $66.00 from $63.00.<\/p>\n
Kforce (KFRC) \u2014 UBS reiterated its Neutral rating.<\/p>\n
Kforce (KFRC) \u2014 UBS also established a price target of $63.00.<\/p>\n
Kinder Morgan (KMI) \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to $40.00 from $38.00.<\/p>\n
Kinder Morgan (KMI) \u2014 Scotiabank maintained its Sector Perform rating and raised its price target to $34.00 from $32.00.<\/p>\n
Kinder Morgan (KMI) \u2014 UBS reiterated its Buy rating.<\/p>\n
KKR (KKR) \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $109.00 from $118.00.<\/p>\n
Knife River (KNF) \u2014 Wolfe Research upgraded its rating from Peer Perform to Outperform.<\/p>\n
Kodiak Gas Services (KGS) \u2014 Bank of America maintained its Buy rating and lowered its price target to $74.00 from $83.00.<\/p>\n
Kymera Therapeutics (KYMR) \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to $146.00 from $135.00.<\/p>\n
Lakeland Financial (LKFN) \u2014 Keefe, Bruyette & Woods maintained its Market Perform rating and raised its price target to $64.00 from $63.00.<\/p>\n
LCI Industries (LCII) \u2014 Roth Capital established a price target of $112.00 without specifying a rating.<\/p>\n
Life Time Group Holdings (LTH) \u2014 Mizuho maintained its Outperform rating and raised its price target to $68.00 from $64.00.<\/p>\n
Life Time Group Holdings (LTH) \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to $54.00 from $53.00.<\/p>\n
Liftoff Mobile (LFTO) \u2014 Wedbush initiated coverage with an Outperform rating and a price target of $25.00.<\/p>\n
M&T Bank (MTB) \u2014 Wolfe Research resumed coverage with an Underperform rating and a price target of $198.00.<\/p>\n
MACOM Technology Solutions (MTSI) \u2014 Raymond James upgraded its rating from Market Perform to Outperform with a price target of $300.00.<\/p>\n
MakeMyTrip (MMYT) \u2014 Bank of America maintained its Buy rating and lowered its price target to $55.00 from $60.00.<\/p>\n
Mama’s Creations (MAMA) \u2014 Stephens initiated coverage with an Overweight rating and a price target of $19.00.<\/p>\n
MasterBrand (MBC) \u2014 DA Davidson reiterated its Neutral rating with a price target of $10.00.<\/p>\n
Match Group (MTCH) \u2014 TD Cowen maintained its Buy rating and raised its price target to $52.00 from $45.00.<\/p>\n
MBX Biosciences (MBX) \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n
MercadoLibre (MELI) \u2014 BTIG reiterated its Buy rating with a price target of $2,150.00.<\/p>\n
MercadoLibre (MELI) \u2014 Citigroup upgraded its rating from Neutral to Buy and lowered its price target to $2,050.00 from $2,100.00.<\/p>\n
Mercer International (MERC) \u2014 CIBC downgraded its rating from Neutral to Sector Underperform.<\/p>\n
Metropolitan Bank Holding (MCB) \u2014 UBS reiterated its Neutral rating.<\/p>\n
Miami International Holdings (MIAX) \u2014 Rosenblatt maintained its Buy rating and lowered its price target to $60.00 from $62.00.<\/p>\n
Microsoft (MSFT) \u2014 Raymond James reiterated its Outperform rating with a price target of $630.00.<\/p>\n
Microsoft (MSFT) \u2014 Wells Fargo reiterated its Overweight rating.<\/p>\n
Mid Penn Bancorp (MPB) \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $40.00 from $42.00.<\/p>\n
Midland States Bancorp (MSBI) \u2014 Stephens maintained its Equal Weight rating and raised its price target to $36.00 from $34.00.<\/p>\n
Moderna (MRNA) \u2014 William Blair downgraded its rating from Outperform to Market Perform.<\/p>\n
Modine Manufacturing (MOD) \u2014 DA Davidson reiterated its Buy rating with a price target of $330.00.<\/p>\n
Moelis & Company (MC) \u2014 JPMorgan maintained its Neutral rating and lowered its price target to $68.00 from $70.00.<\/p>\n
Molina Healthcare (MOH) \u2014 JPMorgan maintained its Neutral rating and raised its price target to $225.00 from $220.00.<\/p>\n
Molina Healthcare (MOH) \u2014 Bernstein reiterated its Outperform rating.<\/p>\n
monday.com (MNDY) \u2014 Needham reiterated its Buy rating with a price target of $125.00.<\/p>\n
monday.com (MNDY) \u2014 UBS reiterated its Buy rating.<\/p>\n
Mosaic (MOS) \u2014 UBS established a price target of $19.00 without specifying a rating.<\/p>\n
Murphy Oil (MUR) \u2014 Goldman Sachs maintained its Neutral rating and raised its price target to $44.00 from $36.00.<\/p>\n
Natera (NTRA) \u2014 BTIG maintained its Buy rating and raised its price target to $430.00 from $320.00.<\/p>\n
NB Bancorp (NBBK) \u2014 Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to $24.00 from $25.00.<\/p>\n
NB Bancorp (NBBK) \u2014 New Street Research established a price target of $24.00 without specifying a rating.<\/p>\n
Newmont (NEM) \u2014 Scotiabank reiterated its Outperform rating and lowered its price target to $148.00 from $149.00.<\/p>\n
Nordic American Tankers (NAT) \u2014 Evercore reiterated its Underperform rating with a price target of $7.00.<\/p>\n
Northrop Grumman (NOC) \u2014 Bernstein maintained its Market Perform rating and raised its price target to $590.00 from $556.00.<\/p>\n
Northwest Natural (NWN) \u2014 Truist initiated coverage with a Hold rating and a price target of $54.00.<\/p>\n
Novavax (NVAX) \u2014 Cantor Fitzgerald reiterated its Overweight rating.<\/p>\n
NRG Energy (NRG) \u2014 Barclays maintained its Overweight rating and lowered its price target to $163.00 from $204.00.<\/p>\n
Nutrien (NTR) \u2014 UBS reiterated its Sell rating.<\/p>\n
Nyxoah (NYXH) \u2014 Cantor Fitzgerald reiterated its Overweight rating with a price target of $3.00.<\/p>\n
Nyxoah (NYXH) \u2014 Raymond James established a price target of $3.00 without specifying a rating.<\/p>\n
Occidental Petroleum (OXY) \u2014 Goldman Sachs maintained its Buy rating and raised its price target to $76.00 from $69.00.<\/p>\n
Occidental Petroleum (OXY) \u2014 Piper Sandler resumed coverage with a Neutral rating and a price target of $94.00, according to Briefing.com; the supplied MarketBeat record lists $69.00.<\/p>\n
Ollie’s Bargain Outlet (OLLI) \u2014 RBC maintained its Outperform rating and raised its price target to $125.00 from $124.00.<\/p>\n
OneSpan (OSPN) \u2014 Rosenblatt downgraded its rating from Buy to Neutral with a price target of $18.00.<\/p>\n
OptimizeRx (OPRX) \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n
Oracle (ORCL) \u2014 Bernstein reiterated its Outperform rating.<\/p>\n
Oric Pharmaceuticals (ORIC) \u2014 Wedbush maintained its Outperform rating and lowered its price target to $14.00 from $17.00.<\/p>\n
Oruka Therapeutics (ORKA) \u2014 H.C. Wainwright reiterated its Buy rating.<\/p>\n
Oruka Therapeutics (ORKA) \u2014 Wedbush reiterated its Outperform rating with a price target of $165.00.<\/p>\n
Ovintiv (OVV) \u2014 Goldman Sachs maintained its Buy rating and raised its price target to $72.00 from $65.00.<\/p>\n
Ovintiv (OVV) \u2014 Stephens maintained its Equal Weight rating and raised its price target to $77.00 from $75.00.<\/p>\n
Owens Corning (OC) \u2014 Bank of America maintained its Buy rating and lowered its price target to $145.00 from $155.00.<\/p>\n
PagSeguro Digital (PAGS) \u2014 Citigroup downgraded its rating from Buy to Neutral and lowered its price target to $8.00 from $13.00.<\/p>\n
Palantir Technologies (PLTR) \u2014 Rosenblatt maintained its Buy rating and raised its price target to $260.00 from $225.00.<\/p>\n
Par Pacific Holdings (PARR) \u2014 Piper Sandler resumed coverage with a Neutral rating and a price target of $94.00.<\/p>\n
Patrick Industries (PATK) \u2014 Roth Capital reiterated its Buy rating with a price target of $96.00.<\/p>\n
Paycom Software (PAYC) \u2014 Citigroup maintained its Neutral rating and raised its price target to $279.00 from $194.00.<\/p>\n
Paycom Software (PAYC) \u2014 Jefferies maintained its Hold rating and raised its price target to $300.00 from $160.00.<\/p>\n
Paylocity (PCTY) \u2014 Citigroup maintained its Buy rating and raised its price target to $208.00 from $168.00.<\/p>\n
PayPal (PYPL) \u2014 BTIG reiterated its Neutral rating.<\/p>\n
PayPal (PYPL) \u2014 Evercore established a price target of $45.00 without specifying a rating.<\/p>\n
PayPal (PYPL) \u2014 Needham reiterated its Hold rating.<\/p>\n
PBF Energy (PBF) \u2014 Piper Sandler’s supplied MarketBeat entry lists a change from Overweight to Neutral with a $94.00 price target; the action requires verification.<\/p>\n
Pinnacle Financial Partners (PNFP) \u2014 Evercore reiterated its Outperform rating.<\/p>\n
Pinnacle Financial Partners (PNFP) \u2014 UBS reiterated its Buy rating.<\/p>\n
Planet Fitness (PLNT) \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to $55.00 from $51.00.<\/p>\n
PNC Financial Services (PNC) \u2014 Wolfe Research resumed coverage with a Peer Perform rating.<\/p>\n
PolyPid (PYPD) \u2014 Oppenheimer initiated coverage with an Outperform rating and a price target of $10.00.<\/p>\n
PPL Corporation (PPL) \u2014 Truist initiated coverage with a Buy rating and a price target of $41.00.<\/p>\n
Principal Financial Group (PFG) \u2014 UBS reiterated its Neutral rating with a price target of $112.00.<\/p>\n
Proto Labs (PRLB) \u2014 Cantor Fitzgerald reiterated its Overweight rating.<\/p>\n
Public Service Enterprise Group (PEG) \u2014 Bank of America maintained its Buy rating and lowered its price target to $85.00 from $87.00.<\/p>\n
Public Storage (PSA) \u2014 UBS reiterated its Neutral rating.<\/p>\n
Quanta Services (PWR) \u2014 Truist maintained its Buy rating and raised its price target to $960.00 from $945.00.<\/p>\n
Rambus (RMBS) \u2014 Evercore reiterated its Outperform rating with a price target of $150.00.<\/p>\n
Rambus (RMBS) \u2014 Rosenblatt reiterated its Buy rating with a price target of $165.00.<\/p>\n
Rambus (RMBS) \u2014 Susquehanna maintained its Neutral rating and raised its price target to $103.00 from $100.00.<\/p>\n
Rambus (RMBS) \u2014 UBS established a price target of $165.00 without specifying a rating.<\/p>\n
Range Resources (RRC) \u2014 Morgan Stanley established a price target of $54.00 without specifying a rating.<\/p>\n
Regions Financial (RF) \u2014 Evercore reiterated its Underperform rating with a price target of $28.00.<\/p>\n
Revolve Group (RVLV) \u2014 UBS reiterated its Neutral rating.<\/p>\n
Reynolds Consumer Products (REYN) \u2014 UBS reiterated its Neutral rating with a price target of $24.00.<\/p>\n
Rithm Capital (RITM) \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to $13.00 from $12.50.<\/p>\n
Ross Stores (ROST) \u2014 Bank of America maintained its Buy rating and lowered its price target to $258.00 from $265.00.<\/p>\n
Ryder System (R) \u2014 Susquehanna maintained its Positive rating and raised its price target to $318.00 from $280.00.<\/p>\n
Scorpio Tankers (STNG) \u2014 Evercore reiterated its Outperform rating with a price target of $97.00.<\/p>\n
Selective Insurance Group (SIGI) \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to $85.00 from $80.00.<\/p>\n
Sensei Biotherapeutics (FTH) \u2014 BTIG reiterated its Buy rating with a price target of $55.00.<\/p>\n
Senseonics Holdings (SENS) \u2014 TD Cowen reiterated its Buy rating with a price target of $15.00.<\/p>\n
SharkNinja (SN) \u2014 TD Cowen maintained its Buy rating and raised its price target to $230.00 from $205.00.<\/p>\n
Sherwin-Williams (SHW) \u2014 Jefferies reiterated its Hold rating with a price target of $353.00.<\/p>\n
Shopify (SHOP) \u2014 Citigroup maintained its Buy rating and raised its price target to $216.00 from $196.00.<\/p>\n
Simpson Manufacturing (SSD) \u2014 Baird maintained its Outperform rating and raised its price target to $210.00 from $205.00.<\/p>\n
Simpson Manufacturing (SSD) \u2014 DA Davidson maintained its Neutral rating and lowered its price target to $203.00 from $212.00.<\/p>\n
Simpson Manufacturing (SSD) \u2014 Stephens maintained its Cautious rating and lowered its price target to $205.00 from $215.00.<\/p>\n
Skydance (SKYD) \u2014 Huber Research issued an upgrade; the supplied entry did not identify the new rating.<\/p>\n
SL Green Realty (SLG) \u2014 Truist maintained its Hold rating and lowered its price target to $48.00 from $57.00.<\/p>\n
Solid Biosciences (SLDB) \u2014 H.C. Wainwright reiterated its Buy rating.<\/p>\n
Sphere Entertainment (SPHR) \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $150.00 from $170.00.<\/p>\n
StepStone Group (STEP) \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $48.00 from $58.00.<\/p>\n
Steven Madden (SHOO) \u2014 BTIG reiterated its Buy rating with a price target of $55.00.<\/p>\n
Summit Therapeutics (SMMT) \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n
Sun Communities (SUI) \u2014 UBS reiterated its Neutral rating.<\/p>\n
Take-Two Interactive (TTWO) \u2014 Bank of America maintained its Buy rating and lowered its price target to $330.00 from $368.00.<\/p>\n
Talen Energy (TLN) \u2014 Bank of America reiterated its Buy rating.<\/p>\n
Talen Energy (TLN) \u2014 Barclays maintained its Overweight rating and lowered its price target to $387.00 from $408.00.<\/p>\n
Talos Energy (TALO) \u2014 Goldman Sachs reiterated its Buy rating with a price target of $22.00.<\/p>\n
Tapestry (TPR) \u2014 Baird maintained its Outperform rating and lowered its price target to $150.00 from $165.00.<\/p>\n
Teekay Tankers (TNK) \u2014 Evercore reiterated its Outperform rating with a price target of $116.00.<\/p>\n
Texas Capital Bancshares (TCBI) \u2014 Citigroup reiterated its Neutral rating.<\/p>\n
TJX Companies (TJX) \u2014 Bank of America maintained its Buy rating and lowered its price target to $170.00 from $175.00.<\/p>\n
TKO Group Holdings (TKO) \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n
TKO Group Holdings (TKO) \u2014 Goldman Sachs maintained its Buy rating and lowered its price target to $215.00 from $220.00.<\/p>\n
Torm (TRMD) \u2014 Evercore reiterated its Outperform rating.<\/p>\n
TPG (TPG) \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $52.00 from $56.00.<\/p>\n
Transcat (TRNS) \u2014 CJS Securities initiated coverage with a Market Outperform rating and a price target of $115.00.<\/p>\n
Travel + Leisure (TNL) \u2014 Stifel established a price target of $91.00 without specifying a rating.<\/p>\n
Trimble (TRMB) \u2014 Loop Capital initiated coverage with a Buy rating and a price target of $76.00.<\/p>\n
Triumph Financial (TFIN) \u2014 DA Davidson established a price target of $70.00 without specifying a rating.<\/p>\n
Truist Financial (TFC) \u2014 Evercore reiterated its Outperform rating with a price target of $55.00.<\/p>\n
Truist Financial (TFC) \u2014 Wolfe Research resumed coverage with a Peer Perform rating.<\/p>\n
TuHURA Biosciences (HURA) \u2014 H.C. Wainwright reiterated its Buy rating with a price target of $10.00.<\/p>\n
Twilio (TWLO) \u2014 Wells Fargo raised its price target to $300.00 from $275.00.<\/p>\n
Tyler Technologies (TYL) \u2014 Needham maintained its Buy rating and raised its price target to $500.00 from $400.00.<\/p>\n
U.S. Bancorp (USB) \u2014 Wolfe Research resumed coverage with a Peer Perform rating.<\/p>\n
UFP Industries (UFPI) \u2014 DA Davidson reiterated its Buy rating with a price target of $105.00.<\/p>\n
Union Pacific (UNP) \u2014 Susquehanna maintained its Positive rating and raised its price target to $345.00 from $333.00.<\/p>\n
UnitedHealth Group (UNH) \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to $531.00 from $529.00.<\/p>\n
UnitedHealth Group (UNH) \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $487.00 from $526.00.<\/p>\n
USCB Financial Holdings (USCB) \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $24.00 from $27.00.<\/p>\n
UWM Holdings (UWMC) \u2014 Compass Point downgraded its rating from Buy to Neutral with a price target of $1.50.<\/p>\n
Varonis Systems (VRNS) \u2014 Stephens downgraded its rating from Overweight to Equal Weight.<\/p>\n
Veritone (VERI) \u2014 Needham reiterated its Buy rating.<\/p>\n
Verizon Communications (VZ) \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $44.00 from $46.00.<\/p>\n
Verizon Communications (VZ) \u2014 BNP Paribas Exane lowered its price target to $45.00 from $46.00.<\/p>\n
Verizon Communications (VZ) \u2014 Citigroup lowered its price target to $53.00 from $55.00.<\/p>\n
Verizon Communications (VZ) \u2014 Daiwa maintained its Buy rating and lowered its price target to $52.00 from $55.00.<\/p>\n
Verizon Communications (VZ) \u2014 Goldman Sachs lowered its price target to $47.00 from $51.00.<\/p>\n
Verizon Communications (VZ) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $50.00 from $52.00.<\/p>\n
Verizon Communications (VZ) \u2014 TD Cowen maintained its Buy rating and lowered its price target to $55.00 from $56.00.<\/p>\n
Vistra (VST) \u2014 Bank of America maintained its Buy rating and lowered its price target to $194.00 from $196.00.<\/p>\n
Vistra (VST) \u2014 Lake Street Capital established a price target of $194.00 without specifying a rating.<\/p>\n
Vital Farms (VITL) \u2014 DA Davidson established a price target of $10.00 without specifying a rating.<\/p>\n
Warby Parker (WRBY) \u2014 BTIG reiterated its Buy rating.<\/p>\n
Waste Connections (WCN) \u2014 UBS reiterated its Buy rating with a price target of $215.00.<\/p>\n
Welltower (WELL) \u2014 UBS reiterated its Buy rating with a price target of $269.00.<\/p>\n
WEX (WEX) \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to $178.00 from $172.00.<\/p>\n
Weyerhaeuser (WY) \u2014 CIBC maintained its Outperformer rating and lowered its price target to $25.00 from $30.00.<\/p>\n
Weyerhaeuser (WY) \u2014 DA Davidson maintained its Buy rating and lowered its price target to $27.00 from $31.00.<\/p>\n
Xencor (XNCR) \u2014 RBC maintained its Outperform rating and raised its price target to $43.00 from $20.00.<\/p>\n
Xencor (XNCR) \u2014 Truist maintained its Buy rating and raised its price target to $40.00 from $29.00.<\/p>\n
Xencor (XNCR) \u2014 Wedbush maintained its Outperform rating and raised its price target to $45.00 from $30.00.<\/p>\n
Xencor (XNCR) \u2014 Wells Fargo maintained its Overweight rating and raised its price target to $44.00 from $30.00.<\/p>\n
Xometry (XMTR) \u2014 Cantor Fitzgerald reiterated its Overweight rating.<\/p>\n
XP (XP) \u2014 Citigroup downgraded its rating from Buy to Neutral and lowered its price target to $15.00 from $25.00.<\/p>\n
YETI Holdings (YETI) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $48.00 from $49.00.<\/p>\n
Zoetis (ZTS) \u2014 UBS reiterated its Neutral rating.<\/p>\n","protected":false},"excerpt":{"rendered":"
Analyst Ratings (USA) Wall Street analysts demonstrated a selective approach to equity valuations, favouring companies with identifiable earnings-growth catalysts while reducing expectations for businesses…<\/p>\n","protected":false},"author":3,"featured_media":20856,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76649","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\n